Dexamethasone in severe respiratory COVID 19 saves lives

December 4, 2021 | RR Baliga, MD, MBA

PodKast: Dexamethasone in severe respiratory COVID 19 saves lives---"Hot of the Press" | Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

Youtube: https://youtu.be/SKYxTmOiNx4

References: 

Low-cost Dexamethasone reduce mortality by up to one third in hospitalized patients with severe pulmonary complications of COVID19 |

Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians

Not Medical Advice or Opinion

Dexamethasone reduced deaths by one-third in ventilated patients (rate ratio 0.65 [95% confidence interval 0.48 to 0.88]; p=0.0003) and by one fifth in other patients receiving oxygen only (0.80 [0.67 to 0.96]; p=0.0021). 

There was no benefit among those patients who did not require respiratory support (1.22 [0.86 to 1.75; p=0.14).

Based on these results, 1 death would be prevented by treatment of around 8 ventilated patients or around 25 patients requiring oxygen alone.

Internal Medicine - Mastermedfacts

Get Free MCQ Question Every Week

Close